title: Pre-exposure prophylaxis for HIV: who will benefit and what are the challenges?
authors.affiliation: Rollins School of Public Health and Emory Center for AIDS Research, Emory University, Atlanta, Georgia 30322, USA. jcurran@emory.edu
authors.forename: James W
authors.initials: JW
authors.lastname: Curran
authors.forename: Richard A
authors.initials: RA
authors.lastname: Crosby
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D015658:HIV Infections / Q000517:prevention & control*; D006284:Health Plan Implementation; D006801:Humans; D009943:Organophosphorus Compounds / Q000008:administration & dosage*; D011322:Primary Prevention
chemical_list: D019380:Anti-HIV Agents; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D009943:Organophosphorus Compounds; D003841:Deoxycytidine